BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1587 related articles for article (PubMed ID: 29411111)

  • 1. Functional morphology of the blood-brain barrier in health and disease.
    Liebner S; Dijkhuizen RM; Reiss Y; Plate KH; Agalliu D; Constantin G
    Acta Neuropathol; 2018 Mar; 135(3):311-336. PubMed ID: 29411111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
    Lossinsky AS; Shivers RR
    Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and Function of the Blood-Brain Barrier (BBB).
    Benz F; Liebner S
    Handb Exp Pharmacol; 2022; 273():3-31. PubMed ID: 33249527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging roles of pericytes in the regulation of the neurovascular unit in health and disease.
    Hill J; Rom S; Ramirez SH; Persidsky Y
    J Neuroimmune Pharmacol; 2014 Dec; 9(5):591-605. PubMed ID: 25119834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential crosstalk between sonic hedgehog-WNT signaling and neurovascular molecules: Implications for blood-brain barrier integrity in autism spectrum disorder.
    Gozal E; Jagadapillai R; Cai J; Barnes GN
    J Neurochem; 2021 Oct; 159(1):15-28. PubMed ID: 34169527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
    Yamazaki Y; Kanekiyo T
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier: structural components and function under physiologic and pathologic conditions.
    Persidsky Y; Ramirez SH; Haorah J; Kanmogne GD
    J Neuroimmune Pharmacol; 2006 Sep; 1(3):223-36. PubMed ID: 18040800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia in the Neurovascular Unit: Blood-Brain Barrier-microglia Interactions After Central Nervous System Disorders.
    Thurgur H; Pinteaux E
    Neuroscience; 2019 May; 405():55-67. PubMed ID: 31007172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angioneurins - Key regulators of blood-brain barrier integrity during hypoxic and ischemic brain injury.
    Kunze R; Marti HH
    Prog Neurobiol; 2019 Jul; 178():101611. PubMed ID: 30970273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Mobility Group Box-1 and Blood-Brain Barrier Disruption.
    Nishibori M; Wang D; Ousaka D; Wake H
    Cells; 2020 Dec; 9(12):. PubMed ID: 33321691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dynamic blood-brain barrier.
    Keaney J; Campbell M
    FEBS J; 2015 Nov; 282(21):4067-79. PubMed ID: 26277326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders.
    Uprety A; Kang Y; Kim SY
    Arch Pharm Res; 2021 May; 44(5):487-498. PubMed ID: 34028650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity.
    Ronaldson PT; Davis TP
    J Cereb Blood Flow Metab; 2020 Dec; 40(1_suppl):S6-S24. PubMed ID: 32928017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine receptor signaling: a key to opening the blood-brain door.
    Bynoe MS; Viret C; Yan A; Kim DG
    Fluids Barriers CNS; 2015 Sep; 12():20. PubMed ID: 26330053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-Induced Modulation of Drug Transporters at the Blood-Brain Barrier Level.
    Al Rihani SB; Darakjian LI; Deodhar M; Dow P; Turgeon J; Michaud V
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.
    Bagchi S; Chhibber T; Lahooti B; Verma A; Borse V; Jayant RD
    Drug Des Devel Ther; 2019; 13():3591-3605. PubMed ID: 31695329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-Brain Barrier Disruption: A Common Driver of Central Nervous System Diseases.
    Segura-Collar B; Mata-Martínez P; Hernández-Laín A; Sánchez-Gómez P; Gargini R
    Neuroscientist; 2022 Jun; 28(3):222-237. PubMed ID: 33446074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
    Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
    Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities.
    Candelario-Jalil E; Dijkhuizen RM; Magnus T
    Stroke; 2022 May; 53(5):1473-1486. PubMed ID: 35387495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-Brain Barrier and Neurodegenerative Diseases-Modeling with iPSC-Derived Brain Cells.
    Wu YC; Sonninen TM; Peltonen S; Koistinaho J; Lehtonen Š
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.